Insiders Organon & Co.

Equities

OGN

US68622V1061

Market Closed - Nyse Other stock markets 16:00:02 2024-06-25 EDT			5-day change	1st Jan Change
20.79 ^USD	-1.56%		+2.16%	+44.17%

05-24	Organon, Henlius' Denosumab Biosimilar HLX14 Gets European Validation	MT
05-24	Shanghai Henlius Biotech, Inc. and Organon Announces That the European Medicines Agency Has Validated the Marketing Authorization Applications for Hlx14	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Philips: new CFO in October	02-28	CF
Organon & Co. Announces Departure of Sandra Milligan as Head of Research and Development Effective January 5, 2024	12-05	CI
Organon Announces Two Leadership Appointments	23-09-05	CI
3M Names Finance Chief Monish Patolawala as President, Bryan Hanson as CEO of Health Care Unit	23-08-22	MT
Organon & Co. Appoints Kirke Weaver as General Counsel and Corporate Secretary, Effective January 1, 2023	22-12-12	CI
ObsEva to Terminate Chief Strategy Officer, 70% of Staff Amid Restructuring	22-09-13	MT
Organon & Co. Announces Resignation of Deborah H. Telman as Executive Vice President, General Counsel and Corporate Secretary, Effective July 22, 2022	22-07-12	CI
Organon & Co. Appoints Meghan Rivera as US Managing Director, Organon	22-03-01	CI
Organon & Co. Announces Executive Changes	21-06-03	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Our Free Content Help you Secure and Increase the Performance of Your Investments

Securing my Investments

fermer